Glioblastoma multiforme epidemiology and demographics: Difference between revisions
(→Gender) |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Glioblastoma is the the most common adult primary intracranial neoplasm worldwide.<ref name=ddd>Epidemiology of glioblastoma multiforme. Dr Dylan Kurda and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/glioblastoma</ref> The incidence of glioblastoma is estimated to be 3.2 cases per 100,000 individuals worldwide.<ref name="pmid25053711">{{cite journal| author=Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS et al.| title=Epidemiologic and molecular prognostic review of glioblastoma. | journal=Cancer Epidemiol Biomarkers Prev | year= 2014 | volume= 23 | issue= 10 | pages= 1985-96 | pmid=25053711 | doi=10.1158/1055-9965.EPI-14-0275 | pmc=PMC4185005 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25053711 }} </ref> Glioblastoma is a common disease that tends to affect older adult and elderly population. The median age at diagnosis is 64 years.<ref name="pmid25053711">{{cite journal| author=Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS et al.| title=Epidemiologic and molecular prognostic review of glioblastoma. | journal=Cancer Epidemiol Biomarkers Prev | year= 2014 | volume= 23 | issue= 10 | pages= 1985-96 | pmid=25053711 | doi=10.1158/1055-9965.EPI-14-0275 | pmc=PMC4185005 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25053711 }} </ref> Males are more commonly affected with glioblastoma than females. The male to female ratio is approximately 1.5:1. Glioblastoma usually affects individuals of the caucasian race. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 13:44, 18 September 2015
|
Glioblastoma multiforme Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glioblastoma multiforme epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Glioblastoma multiforme epidemiology and demographics |
|
FDA on Glioblastoma multiforme epidemiology and demographics |
|
CDC on Glioblastoma multiforme epidemiology and demographics |
|
Glioblastoma multiforme epidemiology and demographics in the news |
|
Blogs on Glioblastoma multiforme epidemiology and demographics |
|
Risk calculators and risk factors for Glioblastoma multiforme epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Glioblastoma is the the most common adult primary intracranial neoplasm worldwide.[1] The incidence of glioblastoma is estimated to be 3.2 cases per 100,000 individuals worldwide.[2] Glioblastoma is a common disease that tends to affect older adult and elderly population. The median age at diagnosis is 64 years.[2] Males are more commonly affected with glioblastoma than females. The male to female ratio is approximately 1.5:1. Glioblastoma usually affects individuals of the caucasian race.
Epidemiology and Demographics
Incidence
- Glioblastoma is the the most common adult primary intracranial neoplasm worldwide.[1]
- The incidence of glioblastoma is estimated to be 3.2 cases per 100,000 individuals worldwide.[2]
Age
- Glioblastoma is a common disease that tends to affect older adult and elderly population.
- The median age at diagnosis is 64 years.[2]
Gender
- Males are more commonly affected with glioblastoma than females. The male to female ratio is approximately 1.5:1.[1]
Race
- Glioblastoma usually affects individuals of the caucasian race. African american, hispanic, and asian individuals are less likely to develop glioblastoma.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Epidemiology of glioblastoma multiforme. Dr Dylan Kurda and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/glioblastoma
- ↑ 2.0 2.1 2.2 2.3 Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS; et al. (2014). "Epidemiologic and molecular prognostic review of glioblastoma". Cancer Epidemiol Biomarkers Prev. 23 (10): 1985–96. doi:10.1158/1055-9965.EPI-14-0275. PMC 4185005. PMID 25053711.